High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients

Human Pathology

Volumn 43, Issue 2, 2012, Pages 269-275

  Seiler, Roland ^a   Von Gunten, Michael ^a   Thalmann, George N ^a   Fleischmann, Achim ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bladder cancer; CD10; Metastases; Prognosis; Tissue microarray

Indexed keywords

BIOLOGICAL MARKER; CD10 PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PRIMARY TUMOR; PROGNOSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; RECURRENCE FREE SURVIVAL; RISK FACTOR; TISSUE MICROARRAY; TREATMENT OUTCOME; TUMOR VOLUME; UROTHELIUM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEPRILYSIN; PROGNOSIS; SURVIVAL RATE; SWITZERLAND; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84856006513     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.04.030     Document Type: Article

References (32)

1. G. Christofori New signals from the invasive front Nature 441 2006 444 450 (Pubitemid 44050139)
2. I.J. Fidler Tumor heterogeneity and the biology of cancer invasion and metastasis Cancer Res 38 1978 2651 2660 (Pubitemid 9001502)
3. M. Horstmann, A.S. Merseburger, and E. von der Heyde Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels J Cancer Res Clin Oncol 131 2005 715 722 (Pubitemid 41577948)
4. S.O. Ikuerowo, M.A. Kuczyk, and R. von Wasielewski p16INK4a expression and clinicopathologic parameters in renal cell carcinoma Eur Urol 51 2007 732 737
5. E. Shinto, H. Tsuda, and H. Ueno Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays Lab Invest 85 2005 257 266 (Pubitemid 40208929)
6. F. Liedberg, H. Anderson, and G. Chebil Tissue microarray based analysis of prognostic markers in invasive bladder cancer: much effort to no avail? Urol Oncol 26 2008 17 24
7. M. Mudryj, E. Reay, L. Beckett, S. Dandekar, R. deVere White, and R. Gandour-Edwards Novel p53/p130 axis in bladder tumors Urology 70 2007 608 612 (Pubitemid 47464506)
8. A. Nocito, L. Bubendorf, and E.M. Tinner Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade J Pathol 194 2001 349 357 (Pubitemid 32624562)
9. E.G. Erdos, and R.A. Skidgel Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones Faseb J 3 1989 145 151
10. E. Caselgrandi, D. Kletsas, and E. Ottaviani Neutral endopeptidase-24.11 (NEP) deactivates PDGF- and TGF-beta-induced cell shape changes in invertebrate immunocytes Cell Biol Int 24 2000 85 90
11. D.M. Nanus Of peptides and peptidases: the role of cell surface peptidases in cancer Clin Cancer Res 9 2003 6307 6309 (Pubitemid 38031813)
12. M. Sumitomo, R. Shen, and D.M. Nanus Involvement of neutral endopeptidase in neoplastic progression Biochim Biophys Acta 1751 2005 52 59 (Pubitemid 41033294)
13. S. Carl-McGrath, U. Lendeckel, M. Ebert, and C. Rocken Ectopeptidases in tumour biology: a review Histol Histopathol 21 2006 1339 1353 (Pubitemid 44614516)
14. M. Erhuma, M. Kobel, and T. Mustafa Expression of neutral endopeptidase (NEP/CD10) on pancreatic tumor cell lines, pancreatitis and pancreatic tumor tissues Int J Can 120 2007 2393 2400 (Pubitemid 46642126)
15. R.K. Ganju, M. Sunday, D.G. Tsarwhas, A. Card, and M.A. Shipp CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation J Clin Invest 94 1994 1784 1791
16. D. Mondada, F.T. Bosman, C. Fontolliet, and W.K. Seelentag Elevated hepatocyte paraffin 1 and neprilysin expression in hepatocellular carcinoma are correlated with longer survival Virchows Arch 448 2006 35 45 (Pubitemid 43177413)
17. K. Ohshima, C. Kawasaki, and H. Muta CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis Histopathology 39 2001 156 162 (Pubitemid 34225042)
18. A. Fleischmann, T. Schlomm, and H. Huland Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients Clin Cancer Res 14 2008 7838 7842
19. C. Langner, M. Ratschek, P. Rehak, L. Schips, and R. Zigeuner CD10 is a diagnostic and prognostic marker in renal malignancies Histopathology 45 2004 460 467 (Pubitemid 39524320)
20. N.A. Makretsov, M. Hayes, B.A. Carter, S. Dabiri, C.B. Gilks, and D.G. Huntsman Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade Mod Pathol 20 2007 84 89 (Pubitemid 44967953)
21. L. Deschamps, A. Handra-Luca, and D. O'Toole CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survival Hum Pathol 37 2006 802 808 (Pubitemid 43902955)
22. S. Bircan, O. Candir, N. Kapucuoglu, T.A. Serel, M. Ciris, and N. Karahan CD10 expression in urothelial bladder carcinomas: a pilot study Urol Int 77 2006 107 113 (Pubitemid 44195767)
23. P. Chu, and D.A. Arber Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma Am J Clin Pathol 113 2000 374 382 (Pubitemid 30217385)
24. K. Koiso, H. Akaza, M. Ohtani, N. Miyanaga, and K. Aoyagi A new tumor marker for bladder cancer Int J Urol 1 1994 33 36
25. R. Murali, and W. Delprado CD10 immunohistochemical staining in urothelial neoplasms Am J Clin Pathol 124 2005 371 379 (Pubitemid 41232923)
26. R.D. Mills, W.H. Turner, A. Fleischmann, R. Markwalder, G.N. Thalmann, and U.E. Studer Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy J Urol 166 2001 19 23 (Pubitemid 32565332)
27. U.E. Studer, H. Danuser, V.W. Merz, J.P. Springer, and E.J. Zingg Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment J Urol 154 1995 49 56
28. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumours 7th ed 2009 Wiley & Sons New York pp 262-5
29. A. Fleischmann, G.N. Thalmann, R. Markwalder, and U.E. Studer Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor J Clin Oncol 23 2005 2358 2365 (Pubitemid 46218729)
30. M. Yilmaz, G. Christofori, and F. Lehembre Distinct mechanisms of tumor invasion and metastasis Trends Mol Med 13 2007 535 541 (Pubitemid 350123764)
31. G. Dalbagni, K. Vora, and M. Kaag Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer Eur Urol 56 2009 903 910
32. G.N. Thalmann, R. Markwalder, O. Shahin, F.C. Burkhard, W.W. Hochreiter, and U.E. Studer Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol 172 2004 70 75 (Pubitemid 41615041)